High Quality Fevipiprant Anti-Hair Loss Pharmaceutical Powder CAS NO.872365-14-5

Min.Order: 10 Gram
Payment Terms: L/C,T/T,MoneyGram

Product Details

Keywords

Fevipiprant
Fevipipran
cas 872365-14-5

Quick Details

ProName: High Quality Fevipiprant Anti-Hair Los...
CasNo: 872365-14-5
Molecular Formula: C19H17F3N2O4S
Appearance: white powder
Application: for hair-loss
DeliveryTime: 3 working days upon payment
PackAge: aluminum foil bag, customized
Port: Shenzhen, Shanghai, HK
ProductionCapacity: 500 Kilogram/Month
Purity: 99%
Storage: cool and dry place
Transportation: email:wonda-chem@outlook.com
LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

Details

Introduction of Fevipiprant:

Fevipiprant (INN; code name QAW039) is a drug being developed by Novartis which acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2 or CRTh2).[1][2][3
As of 2016, it is in Phase III[4] clinical trials for the treatment of asthma.[5]

Setipiprant (INN) (developmental code names ACT-129,968, KYTH-105) is a drug originally developed by Actelionwhich acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2).[1] It was initially researched as a treatment for allergies and inflammatory disorders, particularly asthma, but despite being well tolerated in clinical trials and showing reasonable efficacy against allergen-induced airway responses in asthmatic patients,[2][3] it failed to show sufficient advantages over existing drugs and was discontinued from further development in this application.

Main Information Fevipiprant:

Fevipiprant

CAS 872365-14-5

Chemical name Fevipiprant;Fevipipran

Function of Fevipiprant:

Fevipiprant is the drug for the treatment of hair loss dwindled, perhaps due more to commercial potential and chemical stability reasons than efficacy as the later studies of Setipiprant have focused on different chemical forms of the drug and combining it with various nanoparticles to enhance delivery.